TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition December 16, 2021
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies December 3, 2021
Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual Meeting December 2, 2021
Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update November 17, 2021
